Global Orally Disintegrating Tablet Excipient Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
- SKU ID : GIR-GIR1909200057 14545961
- |
- Publishing Date: 27-Sep-2019
- |
- Region: Global
- |
- No. of pages: 135
Description
The worldwide market for Orally Disintegrating Tablet Excipient is expected to grow at a CAGR of roughly 3.4% over the next five years, will reach 17800 million US$ in 2024, from 15580 million US$ in 2019, according to a new study.
This report focuses on the Orally Disintegrating Tablet Excipient in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
BASF
Ashland
ABF Ingredients
JRS Pharma
Merck KGaA
Roquette
Shin-Etsu
Evonik
DFE Pharma
Meggle Pharma
Anhui Sunhere Pharmaceutical
Fuji Chemical Industries
Daicel Corporation
McePharma (Vivesa holding)
Cargill Incorporated
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Binders
Glidents
Diluents
Disintegrants
Others
Binders had the biggest market share of 37% in 2018.
Anti-Psychotics Drug
Anti-Epileptics Drug
Others
Anti-Epileptics Drug is the greatest segment of Orally Disintegrating Tablet Excipient application, with a share of 37% in 2018.
Chapter 1, to describe Orally Disintegrating Tablet Excipient product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Orally Disintegrating Tablet Excipient, with price, sales, revenue and global market share of Orally Disintegrating Tablet Excipient in 2017 and 2018.
Chapter 3, the Orally Disintegrating Tablet Excipient competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Orally Disintegrating Tablet Excipient breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Orally Disintegrating Tablet Excipient market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Orally Disintegrating Tablet Excipient sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Scope of the Report:
The worldwide market for Orally Disintegrating Tablet Excipient is expected to grow at a CAGR of roughly 3.4% over the next five years, will reach 17800 million US$ in 2024, from 15580 million US$ in 2019, according to a new study.
This report focuses on the Orally Disintegrating Tablet Excipient in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
BASF
Ashland
ABF Ingredients
JRS Pharma
Merck KGaA
Roquette
Shin-Etsu
Evonik
DFE Pharma
Meggle Pharma
Anhui Sunhere Pharmaceutical
Fuji Chemical Industries
Daicel Corporation
McePharma (Vivesa holding)
Cargill Incorporated
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Binders
Glidents
Diluents
Disintegrants
Others
Binders had the biggest market share of 37% in 2018.
Market Segment by Application
s, can be divided into
Anti-Psychotics Drug
Anti-Epileptics Drug
Others
Anti-Epileptics Drug is the greatest segment of Orally Disintegrating Tablet Excipient application, with a share of 37% in 2018.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Orally Disintegrating Tablet Excipient product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Orally Disintegrating Tablet Excipient, with price, sales, revenue and global market share of Orally Disintegrating Tablet Excipient in 2017 and 2018.
Chapter 3, the Orally Disintegrating Tablet Excipient competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Orally Disintegrating Tablet Excipient breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Orally Disintegrating Tablet Excipient market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Orally Disintegrating Tablet Excipient sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
